Market Place
Sourcing Support
Cipla’s generic Ventolin HFA secures USFDA approval
24 Apr 2026 //
INDPHARMAPOST
Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge
06 Apr 2026 //
ECONOMICTIMES
Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement
16 Mar 2026 //
GLOBENEWSWIRE
Cipla Strengthens US Portfolio with The Launch of Generic Saxenda
27 Feb 2026 //
PR NEWSWIRE
Indian Firms Selected To Supply Generic Drugs In China
12 Nov 2025 //
ECONOMICTIMES
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
Cipla CEO: Trump`s order benefits Generics
14 May 2025 //
ECONOMICTIMES
Cipla: US Govt Order Won`t Affect Indian Pharma Players
13 May 2025 //
ECONOMICTIMES
Indian Pharma firms Expand in US Cancer Generics Market
16 Apr 2025 //
BUSINESS STD
Cipla gets USFDA nod for Protein-bound Paclitaxel Injection
14 Apr 2025 //
INDPHARMAPOST
Cipla receives final approval for the generic version of Somatuline Depot Inj
23 May 2024 //
INDIANPHARMAPOST
Cipla gets USFDA nod to market Lanreotide injection
22 May 2024 //
ECONOMICTIMES
GSK licenses companies to make cheap copies of HIV prevention drug
30 Mar 2023 //
REUTERS
Cipla receives US FDA approval for generic Firazyr
13 Jul 2020 //
PHARMABIZ
Cipla to price generic version of COVID-19 drug remdesivir
23 Jun 2020 //
MONEYCONTROL
Cipla share price rises nearly 6% on partnership with Gilead for COVID-19
13 May 2020 //
MONEYCONTROL
FDA to Withdraw Generic Drug
26 Oct 2019 //
RAPS
Cipla launches skin treatment drug in US
26 Sep 2019 //
MONEYCONTROL
Pfizer`s Lyrica market share crumbles under generic onslaught
20 Aug 2019 //
FIERCE PHARMA
InvaGen Pharma gets USFDA approval for neuropathic pain management drug
22 Jul 2019 //
BUSINESS STANDARD
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
24 Nov 2018 //
PATENT LITIGATION
Imbruvica (Ibrutinib) : Pharmacyclics, Janssen Biotech vs. Sun Pharma Global
19 Oct 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Cipla Ltd.
25 Sep 2018 //
PATENT LITIGATION
Dying to Survive: Indian generic medicines have a tale to tell
19 Jul 2018 //
BUSINESS TODAY
Otezla® (apremilast): Celgene Corporation v. Cipla Limited
29 Jun 2018 //
PATENT LITIGATION
VESIcare® (Solifenacin): Astellas Pharma Inc v. Cipla
05 Jun 2018 //
PATENT LITIGATION
Tadalafil : Cipla Limited v. Eli Lilly And Company
01 Jun 2018 //
PATENT LITIGATION
Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin
01 May 2018 //
THE HINDUBUSINESSLINE
Kyprolis® (Carfilzomib) : Onyx Therapeutics v. Cipla Limited
20 Apr 2018 //
PATENT LITIGATION
Imbruvica® (Ibrutinib): Pharmacyclics v. Cipla Limited
12 Feb 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck v. Cipla Limited
25 Jan 2018 //
PATENT LITIGATION
Cipla gets USFDA nod to market generic version of cancer drug Dacogen
20 Nov 2017 //
BUSINESS-STANDARD
Cipla gets USFDA nod for generic version of Renvela tablets
26 Oct 2017 //
ECONOMIC TIMES
USFDA promises faster approvals, Aadhaar must for TB treatment
23 Jun 2017 //
MONEYCONTROL
Sun Pharma, Torrent, DRL & Lupin CLSA’s top pharma picks
14 Apr 2017 //
ECONOMIC TIMES
Margin expansion crucial for Cipla`s stock
13 Apr 2017 //
BUSINESS-STANDARD
Delhi HC Quashes Cipla`s appeal, says it can`t market generics, Novartis` Onbrez
10 Mar 2017 //
ECONOMIC TIMES
Dr. Reddy`s plant problems may derail launch of generic Glivec
09 Feb 2017 //
FIERCE PHARMA
Cipla receives US FDA approval for generic Tricor tablets
19 Dec 2016 //
PHARMABIZ
Cipla gets US FDA approval for generic Baraclude tablets
08 Dec 2016 //
PHARMABIZ
Pharma companies increase investments for global biosimilar push
24 Oct 2016 //
BUSINESS STANDARD
FDA nod for Cipla`s new generic
19 Oct 2016 //
BIOSPECTRUM
Piramal Bulks up in Injectable Generics, Buying Five Drugs from J&J
12 Oct 2016 //
FIERCE PHARMA
Cipla gets USFDA nod for generic anti-depressant drug
30 Aug 2016 //
ECONOMIC TIMES
Cipla, Glenmark in race for hived-off Teva-Allergan generics in US
19 Nov 2015 //
ECONOMIC TIMES
Cipla surges after its partner Sandoz received USFDA nod for a key drug
30 Jul 2015 //
BUSINESS STANDARD
Cipla to Acquire Brazil`s Duomed Produtos for Rs 2.6 crore
09 Apr 2015 //
THE ECONOMIC TIMES
Cipla Revs Up For Generic Sovaldi Launch In India
26 Mar 2015 //
FIERCE PHARMA
German Firm Boehringer Ingelheim’s Patent for Asthma Drug Revoked
10 Mar 2015 //
THE ECONOMIC TIMES
